News

Search here results

• Osimertinib shows promise as new standard-of-care treatment for advanced lung cancer | UCL Cancer Institute - UCL - London's Global University
• Experimental model to study the development of brain cancer in children | UCL Cancer Institute - UCL - London's Global University
• First patient treated with microscopic beads pre-loaded with a targeted cancer drug | UCL Cancer Institute - UCL - London's Global University
• Rucaparib boosts progression-free survival in recurrent ovarian cancer | UCL Cancer Institute - UCL - London's Global University
• First prostate cancer patient scanned using hyperpolarised MRI in Europe | UCL Cancer Institute - UCL - London's Global University
• Professor Adrienne Flanagan awarded OBE in Queen’s Birthday Honours | UCL Cancer Institute - UCL - London's Global University
• Existing drugs could benefit patients with bone cancer, genetic study suggests | UCL Cancer Institute - UCL - London's Global University
• New drug trial effective in shrinking cervical cancer tumours | UCL Cancer Institute - UCL - London's Global University
• FOXFIRE combined analysis study results announced | UCL Cancer Institute - UCL - London's Global University
• Drug improves survival of patients with rare cancer by almost a quarter | UCL Cancer Institute - UCL - London's Global University